Status:

UNKNOWN

A Study of Preoperative Radiation Therapy and Capecitabine in Locally Advanced Rectal Cancer

Lead Sponsor:

Alberta Health services

Conditions:

Rectal Cancer

Neoplasm Metastasis

Eligibility:

All Genders

17+ years

Phase:

PHASE2

Brief Summary

The purpose of this trial is to study the efficacy of preoperative radiation therapy and capecitabine in locally advanced rectal cancer.

Detailed Description

The purpose of this trial is to study the efficacy of preoperative radiation therapy and capecitabine in locally advanced rectal cancer.

Eligibility Criteria

Inclusion

  • Biopsy - proven rectal cancer
  • Transmural rectal wall invasion
  • Karnofsky performance status \>70
  • Normal bone marrow, liver and kidney function

Exclusion

  • Distant metastases
  • Prior pelvic radiation
  • Inflammatory bowel disease
  • Severe ischemic heart disease
  • Anticoagulant therapy
  • Pregnancy

Key Trial Info

Start Date :

January 1 2002

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

Estimated Enrollment :

66 Patients enrolled

Trial Details

Trial ID

NCT00122291

Start Date

January 1 2002

Last Update

January 19 2012

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Tom Baker Cancer Centre

Calgary, Alberta, Canada, T2N 4N2